What are the essential aspects to consider when starting a lung cancer screening program using low-dose CT? And why are quality assurance and standardization such important areas? Dr. Mathias Prokop from Nijmegen, the Netherlands, provides some answers, and also gives some general advice to aspiring researchers.
What are the essential aspects to consider when starting a lung cancer screening program using low-dose CT? And why are quality assurance and standardization such important areas? Dr. Mathias Prokop from Nijmegen, the Netherlands, provides some answers, and also gives some general advice to aspiring researchers.Video from ECR 2019: Mathias Prokop on lung cancer screening
Feb 27, 2019
Latest in Home
PiB-PET/CT detects subtypes in cardiac amyloidosis
December 5, 2025
HPI: 13.5B mL of contrast media administered from 2011 to 2024
December 5, 2025
AI ultrasound tool could reduce unnecessary biopsies by 60%
December 5, 2025
3D CNN model estimates MACE risk from chest CT
December 5, 2025
